Search results for Atmp

<![CDATA[Amgen’s Tarlatamab Approved in China ]]>

<![CDATA[FDA Approves Otarmeni Gene Therapy for OTOF-Related Hearing Loss]]>

AAAbio Introduces High-Specificity Anti-MYCT1 Antibody to Advance Cancer and Gene Regulation Research

AAAbio has launched a highly specific anti-MYCT1 antibody to support cancer and gene regulation research. Designed for techniques such as Western blot, ELISA, and flow cytometry, i...

EMA Accepts Otarmeni Gene Therapy for OTOF-Related Hearing Loss for Review

If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achiev...

- - • Data from the head-to-head study show efdoralprin alfa normalized and maintained functional AAT levels in people living with alpha-1 antitrypsin deficiency - • Efdoralpr...

Spotlight On: Actemra® (tocilizumab) / Tofidence™ (tocilizumab-bavi) / Tyenne® (tocilizumab-aazg) / Avtozma® (tocil...

Tocilizumab Challenged Claim Types in IPRs: Claims are counted in each IPR, so claims from the same patent challenged in multiple IPRs are counted more than once. Within each IPR,...

CAR-T therapy for stiff person syndrome nears approval

No medicines have been approved for stiff person syndrome yet. However, Kyverna Therapeutics' CAR-T cell therapy is headed towards approval. The post CAR-T therapy for stiff perso...

<![CDATA[FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment ]]>

Terremoto raises $108M to pursue development of drugs targeting AKT

The California biotech has one therapy in Phase 1 testing and expects another to advance to the clinic later this year.

Astellas unearths Dyno muscle disorder AAV capsid with $15M option agreement

Following a research collaboration established in 2021, Astellas Pharma has reached an agreement to license a Dyno Therapeutics gene therapy vehicle—an adeno-associated virus (AAV)...

Κυτταρικές θεραπείες: Μύθοι και αλήθειες – Όσα πρέπει να γνωρίζουν οι ασθενείς

Οι κυτταρικές θεραπείες και τα ATMPs φέρνουν επανάσταση στη σύγχρονη ιατρική, προσφέροντας ελπίδα για ασθένειες με περιορισμένες επιλογές. Κεντρικό ρόλο έχουν τα βλαστικά κύτταρα,...